Last Reviewed: Q4 2025 Originally developed to treat Type 2 Diabetes, GLP-1s have since gained FDA approval for a variety of diseases, with new indications continually emerging
Moreover, increased glutathione levels in glioblastoma were associated with higher rates of radiotherapy resistance when compared to cell lines with low GSH [66]
Medical oversight is crucial: tirzepatide is FDA-approved only for diabetes currently, though weight-loss approval is pending
Choosing Between 0.5 mL and 1 mL Syringes by Peptide | Peptide | Typical Dose | Reconstitution (per vial) | Concentration | Draw Volume | Recommended Syringe | |---|---|---|---|---|---| | BPC-157 | 250 to 500 mcg | 5 mg / 2 mL BAC | 2 to 500 mcg/mL | 10, 20 units | 0.5 mL or 1 mL, 31G | | TB-500 | 2,000, 2 to 500 mcg | 10 mg / 2 mL BAC | 5 to 000 mcg/mL | 40, 50 units | 1 mL, 29G | | GHK-Cu | 1,000, 2 to 000 mcg | 50 mg / 5 mL BAC | 10 to 000 mcg/mL | 10, 20 units | 0.5 mL or 1 mL, 31G | | Ipamorelin | 200 to 300 mcg | 5 mg / 2 mL BAC | 2 to 500 mcg/mL | 8, 12 units | 0.5 mL, 31G | | CJC-1295 (no DAC) | 100 to 200 mcg | 2 mg / 1 mL BAC | 2 to 000 mcg/mL | 5, 10 units | 0.5 mL, 31G | The 0.5 mL syringe improves accuracy for any draw below 20 units because each graduation mark represents 1 unit across a shorter, fatter barrel
K., Childress, B
This controversy underscores the importance of using regulated and approved forms of the medication
